Please login to the form below

Not currently logged in
Email:
Password:

GSK vaccines business management shift

Jean Stephenne has been appointed as chairman of GlaxoSmithKline (GSK) Biologicals as part of GSK's planned succession strategy

Jean Stephenne has been appointed as chairman of GlaxoSmithKline (GSK) Biologicals as part of GSK's planned succession strategy.

Mr Stephenne will assume his new position with immediate effect while continuing in his current role as president, GSK Biologicals. Over the next two years operational responsibility for GSK Biologicals will move to Dr Moncef Slaoui, who continues in his current role as chairman of research and development. 

CEO of GSK, Andrew Witty, commented: "Succession planning is fundamental to GSK's long-term success and today's changes are clear evidence that we are taking proactive steps to maintain excellent leadership in our business. Jean has built a world-leading vaccines business and as chairman will continue to be instrumental in driving forward our public health agenda, while Moncef has more than 17 years experience working in the vaccines area and has played a critical role in developing the strong pipeline we have today."

According to Mr Witty, these changes to the business will ensure a continued focus on development and delivery of GSK's vaccine pipeline.

15th March 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...